OP2000: Beginning Phase II/III trial

(see Deals, B5)

Incara Pharmaceuticals Corp. (INCR), Research Triangle Park,

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE